Skip to main content
Log in

Ginseng Panaxoside Rb1 Reduces Body Weight in Diet-Induced Obese Mice

  • Translational Biomedical Research
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Crude extracts from ginseng demonstrated anti-obesity properties. Ginsenoside Rb1 is the main component of ginseng, however, there are only few studies examining its effects in obesity. In the present study, we evaluated its potential anti-obesity effects in the murine model of diet-induced obesity. Seventy male C57BL/6 mice were randomly divided to consume for 12 weeks either chow diet (N = 8) or high-fat (HF) diet (N = 62). The latter mice were then divided into four groups: diet-induced obesity group (DIO; N = 10), obesity-resistant group (OR; N = 10), HF group (N = 5), and the group whose diet was changed from HF to normal diet (DC; N = 5). Intraperitoneal injections of Rb-1 were administered daily to mice in the DIO and OR groups for 3 weeks. Body weight and energy intake were monitored, and fasting blood glucose, lipids, neuropeptide Y, Y2 receptor, and peptide YY were quantified. Compared with HF group, weight gain and food intake of DIO mice with Rb-1 injection was significantly decreased (p < 0.05). Further, levels of blood glucose and some lipids were also decreased in DIO-Rb1 group compared with HF group. Furthermore, Rb1 was also found to modulate serum levels of PYY and NPY, and mRNA expression of NPY, Y2 receptor and PYY in tissue samples of DIO mice. Taken together, ginsenoside Rb1 may be useful in the treatment of obesity via modifying the serum content and mRNA expression of NPY, Y2 receptor and PYY.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leonhardt, M., Hrupka, B., & Langhans, W. (1999). New approaches in the pharmacological treatment of obesity. European Journal of Nutrition, 38, 1–13.

    Article  CAS  PubMed  Google Scholar 

  2. Grundy, S. M. (1998). Multifactorial causation of obesity: Implications for prevention. American Journal of Clinical Nutrition, 1998(67), 563S–572S.

    Google Scholar 

  3. Rebuffe-Scrive, M., Surwit, R., Feinglos, M., Kuhn, C., & Rodin, J. (1993). Regional fat distribution and metabolism in a new mouse model (C57BL/6 J) of non-insulin-dependent diabetes mellitus. Metabolism, 42, 1405–1409.

    Article  CAS  PubMed  Google Scholar 

  4. Astrup, A., Buemann, B., Western, P., Toubro, S., Raben, A., & Christensen, N. J. (1994). Obesity as an adaptation to a high-fat diet: Evidence from a cross-sectional study. American Journal of Clinical Nutrition, 59, 350–355.

    CAS  PubMed  Google Scholar 

  5. Portillo, M. P., Simon, E., Garcia-Calonge, M. A., & Del Barrio, A. S. (1999). Effect of high-fat diet on lipolysis in isolated adipocytes from visceral and subcutaneous WAT. European Journal of Nutrition, 38, 177–182.

    Article  CAS  PubMed  Google Scholar 

  6. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., & Schwartz, M. W. (2006). Central nervous system control of food intake and body weight. Nature, 443, 289–295.

    Article  CAS  PubMed  Google Scholar 

  7. Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P., & Kalra, P. S. (1991). Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proceedings of the National Academy of Sciences USA, 88, 10931–10935.

    Article  CAS  Google Scholar 

  8. Stanley, B. G., Kyrkouli, S. E., & Leibowitz, S. F. (1986). Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides, 7, 1189–1192.

    Article  CAS  PubMed  Google Scholar 

  9. Adrian, T. E., Ferri, G. L., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., & Bloom, S. R. (1985). Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology, 89, 1070–1077.

    CAS  PubMed  Google Scholar 

  10. Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., et al. (2002). Gut hormone PYY(3–36) physiologically inhibits food intake. Nature, 418, 650–654.

    Article  CAS  PubMed  Google Scholar 

  11. Batterham, R. L., & Bloom, S. R. (2003). The gut hormone peptide YY regulates appetite. Annals of the New York Academy of Sciences, 994, 162–168.

    Article  CAS  PubMed  Google Scholar 

  12. Lynch, D. R., Walker, M. W., Miller, R. J., & Snyder, S. H. (1989). Neuropeptide Y receptor binding sites in rat brain: Differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity. Journal of Neuroscience, 9, 2607–2619.

    CAS  PubMed  Google Scholar 

  13. Cheng, Y., Shen, L. H., & Zhang, J. T. (2005). Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacologica Sinica, 26, 143–149.

    Article  CAS  PubMed  Google Scholar 

  14. Xue, J. F., Liu, Z. J., Hu, J. F., Chen, H., Zhang, J. T., & Chen, N. H. (2006). Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway. Brain Research, 1106, 91–98.

    Article  CAS  PubMed  Google Scholar 

  15. Seo, J. Y., Lee, J. H., Kim, N. W., Her, E., Chang, S. H., Ko, N. Y., et al. (2005). Effect of a fermented ginseng extract, BST204, on the expression of cyclooxygenase-2 in murine macrophages. International Immunopharmacology, 5, 929–936.

    Article  CAS  PubMed  Google Scholar 

  16. Kim, J. H., Hahm, D. H., Yang, D. C., Kim, J. H., Lee, H. J., & Shim, I. (2005). Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. Journal of Pharmacological Sciences, 97, 124–131.

    Article  CAS  PubMed  Google Scholar 

  17. Kim, S. H., & Park, K. S. (2003). Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacological Research, 48, 511–513.

    Article  CAS  PubMed  Google Scholar 

  18. Xie, J. T., Wang, C. Z., Ni, M., Wu, J. A., Mehendale, S. R., Aung, H. H., et al. (2007). American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. Journal of Food Science, 72, S590–S594.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Yeo, C. R., Yang, C., Wong, T. Y., & Popovich, D. G. (2011). A quantified ginseng (Panax ginseng C. A. Meyer) extract influences lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Molecules, 16, 477–492.

    Article  CAS  PubMed  Google Scholar 

  20. Yeo, C. R., Lee, S. M., & Popovich, D. G. (2011). Ginseng (Panax quinquefolius) reduces cell growth, lipid acquisition and increases adiponectin expression in 3T3-L1 Cells. Evidence-Based Complementary and Alternative Medicine, 2011, 610625.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Park, S., Ahn, I. S., Kwon, D. Y., Ko, B. S., & Jun, W. K. (2008). Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance beta-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Bioscience, Biotechnology, and Biochemistry, 72, 2815–2823.

    Article  CAS  PubMed  Google Scholar 

  22. Huang, X. F., Han, M., & Storlien, L. H. (2004). Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity. Brain Research Molecular Brain Research, 127, 39–47.

    Article  CAS  PubMed  Google Scholar 

  23. Levin, B. E., & Keesey, R. E. (1998). Defense of differing body weight set points in diet-induced obese and resistant rats. American Journal of Physiology, 274, R412–R419.

    CAS  PubMed  Google Scholar 

  24. Xin, X., Storlien, L. H., & Huang, X. F. (2000). Hypothalamic c-fos-like immunoreactivity in high-fat diet-induced obese and resistant mice. Brain Research Bulletin, 52, 235–242.

    Article  CAS  PubMed  Google Scholar 

  25. Huang, X. F., Yu, Y., Li, Y., Tim, S., Deng, C., & Wang, Q. (2008). Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice. Neurochemical Research, 33, 1881–1888.

    Article  CAS  PubMed  Google Scholar 

  26. Yamamoto, M., Kumagai, A., & Yamamura, Y. (1983). Plasma lipid-lowering and lipogenesis-stimulating actions of ginseng saponins in tumor-bearing rats. American Journal of Chinese Medicine, 11, 88–95.

    Article  CAS  PubMed  Google Scholar 

  27. Attele, A. S., Zhou, Y. P., Xie, J. T., Wu, J. A., Zhang, L., Dey, L., et al. (2002). Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes, 51, 1851–1858.

    Article  CAS  PubMed  Google Scholar 

  28. Sotaniemi, E. A., Haapakoski, E., & Rautio, A. (1995). Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care, 18, 1373–1375.

    Article  CAS  PubMed  Google Scholar 

  29. Yun, S. N., Moon, S. J., Ko, S. K., Im, B. O., & Chung, S. H. (2004). Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Archives of Pharmacal Research, 27, 790–796.

    Article  CAS  PubMed  Google Scholar 

  30. Chung, S. H., Choi, C. G., & Park, S. H. (2001). Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Archives of Pharmacal Research, 24, 214–218.

    Article  CAS  PubMed  Google Scholar 

  31. Park, M. Y., Lee, K. S., & Sung, M. K. (2005). Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-alpha, PPAR-gamma, and LPL mRNA expressions. Life Sciences, 77, 3344–3354.

    Article  CAS  PubMed  Google Scholar 

  32. Shang, W., Yang, Y., Zhou, L., Jiang, B., Jin, H., & Chen, M. (2008). Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. Journal of Endocrinology, 198, 561–569.

    Article  CAS  PubMed  Google Scholar 

  33. Hansen, M. J., Ball, M. J., & Morris, M. J. (2001). Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Research, 892, 130–137.

    Article  CAS  PubMed  Google Scholar 

  34. Wilding, J. P., Gilbey, S. G., Mannan, M., Aslam, N., Ghatei, M. A., & Bloom, S. R. (1992). Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats. Journal of Endocrinology, 132, 299–304.

    Article  CAS  PubMed  Google Scholar 

  35. Gehlert, D. R. (1999). Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides, 1999(33), 329–338.

    Article  Google Scholar 

  36. Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F., & Jeanrenaud, B. (1993). Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology, 133, 1753–1758.

    Article  CAS  PubMed  Google Scholar 

  37. Lin, H. C., & Chey, W. Y. (2003). Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs. Regulatory Peptides, 114, 131–135.

    Article  CAS  PubMed  Google Scholar 

  38. Nguyen, A. D., Herzog, H., & Sainsbury, A. (2011). Neuropeptide Y and peptide YY: Important regulators of energy metabolism. Current opinion in Endocrinology, Diabetes, and Obesity, 18, 56–60.

    Article  CAS  PubMed  Google Scholar 

  39. Chen, C. H., & Rogers, R. C. (1997). Peptide YY and the Y2 agonist PYY-(13–36) inhibit neurons of the dorsal motor nucleus of the vagus. American Journal of Physiology, 273, R213–R218.

    CAS  PubMed  Google Scholar 

  40. le Roux, C. W., Batterham, R. L., Aylwin, S. J., Patterson, M., Borg, C. M., Wynne, K. J., et al. (2006). Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology, 147, 3–8.

    Article  PubMed  Google Scholar 

  41. Batterham, R. L., Cohen, M. A., Ellis, S. M., le Roux, C. W., Withers, D. J., Frost, G. S., et al. (2003). Inhibition of food intake in obese subjects by peptide YY3-36. New England Journal of Medicine, 349, 941–948.

    Article  CAS  PubMed  Google Scholar 

  42. Boey, D., Lin, S., Enriquez, R. F., Lee, N. J., Slack, K., Couzens, M., et al. (2008). PYY transgenic mice are protected against diet-induced and genetic obesity. Neuropeptides, 42, 19–30.

    Article  CAS  PubMed  Google Scholar 

  43. Batterham, R. L., Ffytche, D. H., Rosenthal, J. M., Zelaya, F. O., Barker, G. J., Withers, D. J., et al. (2007). PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature, 450, 106–109.

    Article  CAS  PubMed  Google Scholar 

  44. Nah, S. Y., Kim, D. H., & Rhim, H. (2007). Ginsenosides: Are any of them candidates for drugs acting on the central nervous system? CNS Drug Reviews, 13, 381–404.

    CAS  PubMed  Google Scholar 

  45. Chang, Y., Huang, W. J., Tien, L. T., & Wang, S. J. (2008). Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes). European Journal of Pharmacology, 578, 28–36.

    Article  CAS  PubMed  Google Scholar 

  46. Chen, C. F., Chiou, W. F., & Zhang, J. T. (2008). Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacologica Sinica, 29, 1103–1108.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Prof. Zhang Luoman for statistical analysis of research data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ning Lin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, N., Cai, DL., Jin, D. et al. Ginseng Panaxoside Rb1 Reduces Body Weight in Diet-Induced Obese Mice. Cell Biochem Biophys 68, 189–194 (2014). https://doi.org/10.1007/s12013-013-9688-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9688-3

Keywords

Navigation